Lupus, rheumatoid arthritis, or another autoimmune diagnosis does not automatically rule out plastic surgery. Candidacy depends on disease control, affected organs, medications, healing history, and the proposed operation. A stable patient may be able to proceed with a coordinated plan; an active flare, serious organ involvement, or an unresolved infection may make postponement the better decision.

Does a quiet disease mean the risk is normal?

Good control is helpful, but symptoms alone do not describe the whole disease. Lupus can involve the kidneys, blood cells, heart, or lungs, and some patients have antibodies associated with increased clot risk. Rheumatoid arthritis can affect the lungs and neck as well as joints. The anesthesia team needs to know about limited neck movement, breathing symptoms, and previous difficulties with anesthesia.

Describe how the disease affects ordinary activities and when the last flare occurred. Bring your rheumatologist's recent assessment and relevant testing rather than assuming that every autoimmune condition requires the same laboratory panel. A diagnosis that has been stable for years may call for a different plan than one recently treated with escalating medication.

Should I stop steroids, methotrexate, or a biologic?

Do not stop or reschedule prescription treatment on your own. Some medicines may be continued, while others may need carefully timed interruption. Stopping treatment can provoke a flare, and a flare may require stronger treatment. Long-term corticosteroid use also requires specific planning; suddenly stopping it can be unsafe.

The ACR/AAHKS medication guideline concerns elective hip and knee replacement. It is a useful clinical reference, but its dosing schedules are not a universal plastic surgery protocol. The rheumatologist, surgeon, and anesthesia clinician should decide what applies to your procedure, how medication changes will be communicated, and what conditions must be met before restarting anything held.

Factor in your historyWhy it mattersWhat to clarify
Recent flare or increasing treatmentDisease may not be stable enoughWhether control should improve first
Steroids or immune-modifying medicinesInfection, healing, and flare risks interactA written plan from the treating team
Kidney, lung, heart, or clotting involvementRisk extends beyond the skin incisionAppropriate medical and anesthesia assessment
Prior infection or poor wound healingMay change procedure scope and settingWhether a smaller or staged operation is preferable

Does the size of the operation change candidacy?

A short localized procedure and a lengthy combined body operation do not create the same physiological demands. A breast reduction or tummy tuck also requires healthy blood supply across healing tissues. Discuss whether the expected benefit justifies the planned extent of surgery, rather than treating a medical clearance letter as approval for any combination.

Nutrition, smoking, blood pressure, and glucose control still matter alongside the autoimmune condition. The guide to diabetes and surgical readiness explains one additional factor when it applies. Poorly controlled health conditions or an inability to coordinate medication timing may make an elective procedure unsuitable for now.

Is this the same question as breast implant illness?

No. Planning surgery with a diagnosed autoimmune disease is different from evaluating systemic symptoms attributed to an implant. Neither question can be answered by a blanket promise that an implant causes, prevents, or cures autoimmune disease. The article on breast implant illness and the evidence addresses that separate decision.

Coordinate the disease plan before choosing a surgery date

Bring a current medication list with doses, infusion dates, recent flares, infection history, and your rheumatologist's contact information. Ask whether the operation should be limited or staged and who will issue the final medicine instructions. The goal of the consultation is to identify a workable period of stability and an appropriate procedure, not to decide candidacy from the diagnosis alone.